Publication: Inhibition of cAMP-Activated Intestinal Chloride Secretion by Diclofenac: Cellular Mechanism and Potential Application in Cholera
dc.contributor.author | Pawin Pongkorpsakol | en_US |
dc.contributor.author | Nutthapoom Pathomthongtaweechai | en_US |
dc.contributor.author | Potjanee Srimanote | en_US |
dc.contributor.author | Sunhapas Soodvilai | en_US |
dc.contributor.author | Varanuj Chatsudthipong | en_US |
dc.contributor.author | Chatchai Muanprasat | en_US |
dc.contributor.other | Mahidol University | en_US |
dc.contributor.other | Thammasat University | en_US |
dc.date.accessioned | 2018-11-09T02:34:15Z | |
dc.date.available | 2018-11-09T02:34:15Z | |
dc.date.issued | 2014-09-01 | en_US |
dc.description.abstract | © 2014 Pongkorpsakol et al. Cyclic AMP-activated intestinal Cl−secretion plays an important role in pathogenesis of cholera. This study aimed to investigate the effect of diclofenac on cAMP-activated Cl−secretion, its underlying mechanisms, and possible application in the treatment of cholera. Diclofenac inhibited cAMP-activated Cl−secretion in human intestinal epithelial (T84) cells with IC50of ∼20 µM. The effect required no cytochrome P450 enzyme-mediated metabolic activation. Interestingly, exposures of T84 cell monolayers to diclofenac, either in apical or basolateral solutions, produced similar degree of inhibitions. Analyses of the apical Cl−current showed that diclofenac reversibly inhibited CFTR Cl−channel activity (IC50∼10 µM) via mechanisms not involving either changes in intracellular cAMP levels or CFTR channel inactivation by AMP-activated protein kinase and protein phosphatase. Of interest, diclofenac had no effect on Na+-K+ATPases and Na+-K+-Cl−cotransporters, but inhibited cAMP-activated basolateral K+channels with IC50of ∼3 µM. In addition, diclofenac suppressed Ca2+-activated Cl−channels, inwardly rectifying Cl−channels, and Ca2+-activated basolateral K+channels. Furthermore, diclofenac (up to 200 µM; 24 h of treatment) had no effect on cell viability and barrier function in T84 cells. Importantly, cholera toxin (CT)-induced Cl−secretion across T84 cell monolayers was effectively suppressed by diclofenac. Intraperitoneal administration of diclofenac (30 mg/kg) reduced both CT and Vibrio cholerae-induced intestinal fluid secretion by ∼70% without affecting intestinal fluid absorption in mice. Collectively, our results indicate that diclofenac inhibits both cAMP-activated and Ca2+-activated Cl−secretion by inhibiting both apical Cl−channels and basolateral K+channels in intestinal epithelial cells. Diclofenac may be useful in the treatment of cholera and other types of secretory diarrheas resulting from intestinal hypersecretion of Cl−. | en_US |
dc.identifier.citation | PLoS Neglected Tropical Diseases. Vol.8, No.9 (2014) | en_US |
dc.identifier.doi | 10.1371/journal.pntd.0003119 | en_US |
dc.identifier.issn | 19352735 | en_US |
dc.identifier.issn | 19352727 | en_US |
dc.identifier.other | 2-s2.0-84907587752 | en_US |
dc.identifier.uri | https://repository.li.mahidol.ac.th/handle/20.500.14594/34200 | |
dc.rights | Mahidol University | en_US |
dc.rights.holder | SCOPUS | en_US |
dc.source.uri | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84907587752&origin=inward | en_US |
dc.subject | Medicine | en_US |
dc.subject | Pharmacology, Toxicology and Pharmaceutics | en_US |
dc.title | Inhibition of cAMP-Activated Intestinal Chloride Secretion by Diclofenac: Cellular Mechanism and Potential Application in Cholera | en_US |
dc.type | Article | en_US |
dspace.entity.type | Publication | |
mu.datasource.scopus | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84907587752&origin=inward | en_US |